Mariam Mathew George Research Associate in Pharmacology

Research Associate in Pharmacology, Pharmacology , Weill Cornell Medical College 2024 -
Postdoctoral Associate in Pharmacology, Pharmacology , Weill Cornell Medical College 2022 - 2024

Publications

Sort by

Co-Author Network

CD8+ T Cell-Dependent Antitumor Activity In Vivo of a Mass Spectrometry-Identified Neoepitope despite Undetectable CD8+ Immunogenicity In Vitro. Journal of immunology (Baltimore, Md. : 1950). 2023 Academic Article GET IT
Times cited: 2
APR-246 increases tumor antigenicity independent of p53. Life science alliance. 2023 Academic Article GET IT
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Science translational medicine. 2022 Academic Article GET IT
An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejection. The Journal of clinical investigation. 2021 Academic Article GET IT
Times cited: 23
Neoepitopes as cancer immunotherapy targets: key challenges and opportunities. Immunotherapy. 2017 Review GET IT
Times cited: 56
Zinc Induces Dendritic Cell Tolerogenic Phenotype and Skews Regulatory T Cell-Th17 Balance. Journal of immunology (Baltimore, Md. : 1950). 2016 Academic Article GET IT
Times cited: 58

Sort by

Co-investigator Network

Characterizing the Role of Structural Genomic Instability in Generating Actionable Neoantigens in Pediatric Solid Tumors awarded by Starr Cancer Consortium Key Personnel 2024 - 2026
Evolutionary models for optimized design of personalized cancer vaccines awarded by National Heart, Lung, & Blood Institute Key Personnel 2023 - 2025